Cantaloupe Inc (CTLP) concluded trading on Thursday at a closing price of $11.11, with 5.73 million shares of worth about $63.63 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 37.50% during that period and on July 17, 2025 the price saw a gain of about 0.18%. Currently the company’s common shares owned by public are about 73.04M shares, out of which, 66.20M shares are available for trading.
Stock saw a price change of 0.73% in past 5 days and over the past one month there was a price change of 1.09%. Year-to-date (YTD), CTLP shares are showing a performance of 57.37% which increased to 16.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.82 but also hit the highest price of $11.36 during that period. The average intraday trading volume for Cantaloupe Inc shares is 1.50 million. The stock is currently trading 0.78% above its 20-day simple moving average (SMA20), while that difference is up 14.94% for SMA50 and it goes to 23.50% higher than SMA200.
Cantaloupe Inc (NASDAQ: CTLP) currently have 73.04M outstanding shares and institutions hold larger chunk of about 75.60% of that.
The stock has a current market capitalization of $814.22M and its 3Y-monthly beta is at 1.18. PE ratio of stock for trailing 12 months is 13.99, while it has posted earnings per share of $0.79 in the same period. Its PEG reads 0.23 and has Quick Ratio of 1.21 while making debt-to-equity ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CTLP, volatility over the week remained 0.51% while standing at 0.41% over the month.
Stock’s fiscal year EPS is expected to rise by 480.00% while it is estimated to decrease by -46.90% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by B. Riley Securities on June 17, 2025 offering a Neutral rating for the stock and assigned a target price range of between $11.50 and $11.20 to it. On February 23, 2024, The Benchmark Company Initiated their recommendations, while on October 03, 2023, Berenberg Initiated their ratings for the stock with a price target of $9. Stock get a Buy rating from B. Riley Securities on August 17, 2023.
